Rockwell Medical (RMTI) Tops Q4 EPS by 9c ; Offers Guidance
Tweet
Share
E-mailGet Alerts RMTI Hot Sheet
Price: $7.99 --0%
Revenue Growth %: +14.9%
Financial Fact:
Research and Product Development: 1.26M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +14.9%
Financial Fact:
Research and Product Development: 1.26M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Rockwell Medical (NASDAQ: RMTI) reported Q4 EPS of $0.02, $0.09 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $22.1 million versus the consensus estimate of $22.63 million.
GUIDANCE:
Rockwell Medical sees FY2024 revenue of $84-88 million, versus the consensus of $98.01 million.
For earnings history and earnings-related data on Rockwell Medical (RMTI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- UiPath Inc. (PATH) Reports In-Line Q2 EPS; offers guidance
- lululemon athletica (LULU) Tops Q2 EPS by $1.10, Cuts Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
